Home Initial presentations and associated clinical findings in patients with classical congenital adrenal hyperplasia
Article
Licensed
Unlicensed Requires Authentication

Initial presentations and associated clinical findings in patients with classical congenital adrenal hyperplasia

  • Asmaa Adel Milyani ORCID logo , Abdulmoein Eid Al-Agha EMAIL logo and Mashael Al-zanbagi
Published/Copyright: May 11, 2018

Abstract

Background:

The objective of this study was to investigate the initial presenting features of children with classical congenital adrenal hyperplasia (CAH).

Methods:

This is a descriptive retrospective study over a period of 5 years. Data analysis was performed using Statistical Package for Social Science.

Results:

Ambiguous genitalia (AG) was the commonest initial presentation marking 50.7% of the patients. On the other hand, 33.3% presented with a salt-losing crisis, 4.1% of whom presented with shock, while 14.5% had a combined presentation of both AG and a salt-losing crisis.

Conclusions:

CAH should be highly suspected in all females born with AG. Contrarily, affected male newborns more frequently present with a salt-losing crisis, and considering the recent institution of newborn screening in Saudi Arabia, earlier detection in these children is anticipated.


Corresponding author: Abdulmoein Eid Al-Agha, MBBS, DCH, CABP, FRCPCH, Professor of Paediatric Endocrinology, King Abdulaziz University Hospital, Paediatric Department, P.O. Box 80215, Jeddah 21589, Saudi Arabia, Fax: +966 2 640 3841, +966 2 6408353

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Sahakitrungruang T. Clinical and molecular review of atypical congenital adrenal hyperplasia. Ann Pediatr Endocrinol Metab 2015;20:1–7.10.6065/apem.2015.20.1.1Search in Google Scholar

2. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005;365:2125–36.10.1016/S0140-6736(05)66736-0Search in Google Scholar

3. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;349:776–88.10.1056/NEJMra021561Search in Google Scholar

4. Khan AH, Aban M, Raza J, Ul Haq N, Jabbar A, et al. Ethnic disparity in 21-hydroxylase gene mutations identified in Pakistani congenital adrenal hyperplasia patients. BMC Endocr Disord 2011;11:5.10.1186/1472-6823-11-5Search in Google Scholar

5. Valea A. Morbid child obesity with possible Rohhadnet-Rohhad syndrom. Case report. Acta Endocrinol 2014;10:501–10.10.4183/aeb.2014.501Search in Google Scholar

6. Al Jurayyan NA. Congenital adrenal hyperplasia in Saudi Arabia. IJHSR 2016;6:302–10.Search in Google Scholar

7. Witchel SF, Azziz R. Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010;2010:1–11.10.1155/2010/625105Search in Google Scholar

8. Knowles RL, Khalid JM, Oerton JM, Hindmarsh PC, Kelnar CJ, et al. Late clinical presentation of congenital adrenal hyperplasia in older children: findings from national paediatric surveillance. Arch Dis Child 2014;99:30–4.10.1136/archdischild-2012-303070Search in Google Scholar

9. Grunieiro-Papendieck L, Chiesa A, Mendez V, Prieto L. Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina. J Pediatr Endocrinol Metab 2008;21:73–8.10.1515/JPEM.2008.21.1.73Search in Google Scholar

10. Huynh T, McGown I, Cowley D, Nyunt O, Leong GM, et al. The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency. Clin Biochem Rev 2009;30:75–86.Search in Google Scholar

11. Alshabab L, Kaddoura A, Alebrahim A, Al-Fahour S. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a five-year retrospective study in the Children’s Hospital of Damascus, Syria. Qatar Med J 2015;2015:11.10.5339/qmj.2015.11Search in Google Scholar

12. Dar SA, Charoo BA, Qazi IA, Bhat JI, Sheikh MA, et al. Clinical profile of patients with congenital adrenal hyperplasia due to 21 hydroxylase defiiciency. NJMR 2016;6:177–80.Search in Google Scholar

13. Pang S, Clark A, Neto EC, Giugliani R, Dean H, et al. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening (Elsevier) 1993;2:105–39.10.1016/0925-6164(93)90024-DSearch in Google Scholar

14. Thambiah SC, Ahmad Z, Hambali Z, Osman M, Zain MM, et al. Clinical presentation of congenital adrenal hyperplasia in selected multiethnic paediatric population. Malaysian J Med Heal Sci 2015;11:77–83.Search in Google Scholar

15. Ghizzoni L, Mastorakos G, Vottero A, Magiakou MA, Chrousos GP, et al. Spontaneous cortisol and growth hormone secretion interactions in patients with nonclassic 21-hydroxylase deficiency (NCCAH) and control children. J Clin Endocrinol Metab 1996;81:482–7.10.1210/jcem.81.2.8636254Search in Google Scholar

16. Ghizzoni L, Mastorakos G, Street ME, Vottero A, Mazzardo G, et al. Spontaneous thyrotropin and cortisol secretion interactions in patients with nonclassical 21-hydroxylase deficiency and control children. J Clin Endocrinol Metab 1997;82:3677–83.10.1210/jc.82.11.3677Search in Google Scholar

17. El-hazmi MA, Warsy AS, Sulaimani R. Consanguinity among the Saudi Arabian population. J Med Genet 1995;32:623–6.10.1136/jmg.32.8.623Search in Google Scholar PubMed PubMed Central

18. Al-Jurayyan N, Al-Herbish AS, Abo Bakr AM, Al-Rabeeah AA, Al-Samarrai AI, et al. Congenital adrenal hyperplasia in a referral hospital in Saudi Arabia: epidemiology, pattern and clinical presentation. Ann Saudi Med 1995;15:447–50.10.5144/0256-4947.1995.447Search in Google Scholar PubMed

Received: 2018-1-17
Accepted: 2018-4-5
Published Online: 2018-5-11
Published in Print: 2018-6-27

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Congenital hypothyroidism
  4. Original Articles
  5. Does initial dosing of levothyroxine in infants with congenital hypothyroidism lead to frequent dose adjustments secondary to iatrogenic hyperthyroidism on follow-up?
  6. Incidence of congenital hypothyroidism in China: data from the national newborn screening program, 2013–2015
  7. The etiologies and incidences of congenital hypothyroidism before and after neonatal TSH screening program implementation: a study in southern Thailand
  8. Current status of the congenital hypothyroidism neonatal screening program in Adana Province, Turkey
  9. Risk of hypoglycemia in youth with type 2 diabetes on insulin
  10. Metabolic risk factors in adolescent girls with type 1 diabetes
  11. Definition of reference ranges for β-isomerized carboxy-terminal telopeptide collagen type I for children and adolescents
  12. Brown adipose tissue in young adults who were born preterm or small for gestational age
  13. Circulating soluble RAGE and cell surface RAGE on peripheral blood mononuclear cells in healthy children
  14. Predictors of bone maturation, growth rate and adult height in children with central precocious puberty treated with depot leuprolide acetate
  15. Trends in the use of puberty blockers among transgender children in the United States
  16. Initial presentations and associated clinical findings in patients with classical congenital adrenal hyperplasia
  17. Cardiac examination in children with Laron syndrome undergoing mecasermin therapy
  18. Five novel ALMS1 gene mutations in six patients with Alström syndrome
  19. Case Reports
  20. Cutaneous mucormycosis as a presenting feature of type 1 diabetes in a boy – case report and review of the literature
  21. Severe lactic acidosis in an extremely low birth weight infant due to thiamine deficiency
  22. Exertional rhabdomyolysis in carbonic anhydrase 12 deficiency
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2018-0029/html
Scroll to top button